Gene · 5538
Papers1,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression. | Cell Discov | 2026 | 41730846 | PubTator, text mining | PubMed |
| Six-Week Changes in Pain Biomarkers Following Reverse Total Shoulder Arthroplasty: A Prospective Cohort Study. | medRxiv | 2026 | 41728337 | PubTator, text mining | PubMed |
| Deficient de-S-acylation in aging and CLN1 contributes to lyso-mitochondrial dysfunction, lipid dyshomeostasis, and resultant lipofuscin biogenesis. | Res Sq | 2026 | 41727595 | PubTator, text mining | PubMed |
| Proteomic Insights into Heroin Use: Links to Neurodegeneration. | Mol Neurobiol | 2026 | 41721130 | PubTator, text mining | PubMed |
| cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis. | Nat Commun | 2026 | 41708603 | PubTator, text mining | PubMed |
| Protocol for Personalised Prediction of Persistent Postsurgical Pain. | BMJ Open | 2026 | 41638723 | PubTator, text mining | PubMed |
| Region-resolved proteomic map of the human brain: functional interconnections and neurological implications. | Signal Transduct Target Ther | 2026 | 41633974 | PubTator, text mining | PubMed |
| Pilot Study of Fingolimod Treatment in Neuronal Ceroid Lipofuscinosis Type 1. | Neurol Genet | 2026 | 41630928 | PubTator, text mining | PubMed |
| Quantitative Analysis Reveals Hitchhiking Drives Polysorbate Hydrolase Persistence Via Host Cell Protein-Antibody Interactions. | Biotechnol Bioeng | 2026 | 41623200 | PubTator, text mining | PubMed |
| PIK3CA Mutations Downregulate PPT1 to Promote Adipogenesis by Suppressing P300 Depalmitoylation and Phase Separation. | Adv Sci (Weinh) | 2026 | 41610323 | PubTator, text mining | PubMed |
| Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellofemoral Pain Syndrome: A Randomized Trial. | Med Sci Monit | 2026 | 41606964 | PubTator, text mining | PubMed |
| Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier. | Mol Genet Metab | 2026 | 41576655 | PubTator, text mining | PubMed |
| No significant modulation of pressure pain sensitivity and cardioception after transauricular vagal nerve stimulation. | Pain Rep | 2026 | 41562118 | PubTator, text mining | PubMed |
| Frozen Shoulder Is More Than Local Pain: Widespread Sensory Hyperalgesia or Hypoesthesia? | Eur J Pain | 2026 | 41542952 | PubTator, text mining | PubMed |
| Distinct lysosomal dysfunction patterns of GRN deficiency in the CNS implicate progranulin in cell type-specific protein sorting. | bioRxiv | 2026 | 41509379 | PubTator, text mining | PubMed |
| Comparative effects of static, classical, and sham dry needling on muscle properties and autonomic nervous system activity in cervical myofascial pain syndrome. | Complement Ther Med | 2026 | 41386496 | PubTator, text mining | PubMed |
| Palmitoyl-protein thioesterase 1 mediated depalmitoylation regulates lipid accumulation in the oleaginous fungus Mucor circinelloides. | Biochim Biophys Acta Mol Cell Biol Lipids | 2026 | 41067372 | PubTator, text mining | PubMed |
| Targeted lipidomics meets transcriptomics: how cinobufagin rewires fatty acid, sphingolipid, and glycerophospholipid metabolism to combat hepatoma cell growth. | Front Pharmacol | 2025 | 41737012 | PubTator, text mining | PubMed |
| Myofascial release therapy in patients with cervical myofascial pain syndrome: A randomized-controlled trial. | Turk J Phys Med Rehabil | 2025 | 41717515 | PubTator, text mining | PubMed |
| Model-based economic evaluation of pharmacopuncture for chronic low back pain: a 3-year Markov analysis. | Front Public Health | 2025 | 41613092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5538/papers?page=3